Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01452984 · ClinicalTrials.gov registry record

Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project

A clinical trial of Non-Melanoma Skin Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
16
Enrollment target
1
Study location

NCT01452984 is a study of Non-Melanoma Skin Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 16 participants, below the 55-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01452984, a study of Non-Melanoma Skin Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

Mohs surgery excises non-melanoma skin cancer tumors of the head and neck while preserving maximum healthy tissue, an advantageous characteristic when dealing with the cosmetic and functional cervifacial region. Yet, treatment can result in changes to function and appearance with effects on quality of life. This project uses Grounded Theory to explore the Mohs surgery experience of NMSC patients who have head and neck lesions through interview and observation of the surgical appointment.

Conditions Studied

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2011-07
Est. Completion 2013-12

What the Registry Record Tells You About NCT01452984

The ClinicalTrials.gov registry entry for NCT01452984 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55-participant average among 5 other Non-Melanoma Skin Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01452984 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01452984 about?

NCT01452984 is a clinical study titled "Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project". Mohs surgery excises non-melanoma skin cancer tumors of the head and neck while preserving maximum healthy tissue, an advantageous characteristic when dealing with the cosmetic and functional cervifacial region. Yet, treatment can result in changes to function and appearance with effects on quality ...

What is the current status of trial NCT01452984?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-07. Estimated completion is 2013-12.

What conditions does trial NCT01452984 study?

This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.

Who is sponsoring clinical trial NCT01452984?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01452984 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Melanoma Skin Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.